Milestone check-ins parents fill on a chat app before each paediatric visit
TL;DR Babblewise sends parents a short milestone questionnaire on a chat app the day before their child's routine paediatric visit. The doctor sees the answers, with unmet milestones highlighted, before the child walks in. Paediatric clinics pay a monthly fee, and a rushed vaccine visit becomes a chance to spot delays.
Delays that get caught early are easier to help with, but in India they're often noticed late. A population study of 718 children under five in Tamil Nadu found 73% had excessive screen time, which was strongly linked with language and multi-domain delays[1]. One Mumbai child development centre says more than 52 million Indian children have developmental disabilities and fewer than a quarter get quality care. That figure is the organisation's own[2].
Vaccine visits are frequent in the first two years, but they're short. Parents forget what they wanted to ask, and the doctor rarely has time to run through every milestone.
What it does, in regulatory terms: a record-keeping and visit-preparation tool for clinics. It is not screening, diagnosis or treatment. Babblewise collects the parent's answers and shows them to the paediatrician, who decides whether to run a validated screening test or refer. Check with a regulatory adviser whether Indian medical-device rules for software apply before you make any stronger claim.
Each check-in has 8–12 age-matched questions with pictures, in the parent's language. The clinic dashboard lists the day's patients with any unmet milestones flagged, and after the visit parents get two or three play ideas the doctor picked.
The seed pitched AI that tracks development, and I've reframed that. The CDC, whose free milestone checklists cover two months to five years, says such checklists are not a substitute for standardised, validated screening tools[3]. An AI layer on top would promise more than the evidence supports, so Babblewise keeps the doctor in charge and the software as a prompt.
Paediatric clinics and small children's hospitals pay, maybe ₹2,000–5,000 a month per doctor (my estimate). Parents use it free. For comparison, parents abroad do pay for consumer apps - one milestone app charges US$7 a month, about ₹680[4]. Going through the clinic means you never have to ask Indian parents to pay for something they can't easily judge themselves.
Parents and clinics already run appointments on a chat app. The DPDP Rules now exempt clinics and health professionals from some child-data limits, but only when they're providing health services to the child[5]. That gives a clinic-led tool a much clearer legal path than a consumer app that profiles kids.
There's no public figure for spending on developmental check-in software in India. The narrowest signal is clinical need, with 73% excessive screen time in one under-five sample, linked to delay[1]. Adjacent - one milestone app claims 11 million+ families in 180+ countries[4], which shows parents do engage with milestone tracking. Neither proves Indian clinics will pay though.
The CDC's Milestone Tracker app and checklists are free, but they're built for the US[3]. Consumer milestone apps sell activities and milestone tracking straight to parents[4]. A few child development centres offer clinical assessment and early intervention in Mumbai[2]. The gap is a clinic-owned check-in in Indian languages that fits inside a 10-minute vaccine visit. Honestly, the real incumbent is the paper chart.
| Difficulty | Moderate (36/100) |
| Starting capital | ₹35–60 L |
| Time to launch | 6–9 months |
The software is the easy bit. Content and trust are the hard parts, because developmental paediatricians have to adapt the questions to Indian languages and culture without copying copyrighted screening tools. Selling to busy doctors is slow too, and they'll want a peer to vouch for it before they try it.
There's no licence for a visit-preparation tool as such, but the medical-device question needs a written answer before you sell.
Building this outside India? The categories above usually have a local equivalent, so check with your own regulator.
AI must not decide whether a child is delayed or tell a parent that all is well. Babblewise is visit preparation, not screening or diagnosis, and every flag goes to the doctor.
Want to work out the AI layer for Babblewise? Talk to Yash →
Here's what can go south -
I'd back this for a founder with a paediatric or child-development background, or one with a respected developmental paediatrician as co-founder. If you're a consumer-app founder chasing downloads then it's a poor fit. Prove one thing first - that doctors in five clinics open the flagged list in 80% of visits for a month.
Expect roughly ₹35–60 L, much of it going on clinically reviewed content in Indian languages and slow sales to paediatricians.
Not for visit preparation, but software claiming to screen or diagnose may fall under medical-device rules. Get written regulatory advice and follow the DPDP child-data rules.
Yes, if you adapt the questions and check local medical-device and child-data rules. Free checklists like the CDC's already exist in the US, so the clinic workflow is your edge.
The free Babblewise validation kit has the line-by-line capital breakdown, the effort scoring, the data-protection and device-rule checklist, a 14-day validation sprint with pass/fail targets, a 90-day launch plan, 10 interview questions for paediatricians and parents, and 5 assumptions to test. Download the kit →
Thinking about building Babblewise or something close to it? The make-or-break work is getting paediatricians to use the check-in inside a short visit, and that's the kind of thing I help founders figure out. If you need a hand, you know where to find me. Talk to Yash →
For illustration only. Names are fictional and ideas hypothetical; sourced facts are real but may be out of date. Nothing here is legal, financial or professional advice, and Yash Khatri is not personally liable for any use of it. Read the full disclaimer.